Physician profile
John Ciccone
NPI 1750378824
$4,352.56
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,114 · 2020: $1,171 · 2021: $932 · 2022: $14.28 · 2023: $45.87 · 2024: $75.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $690.91 | 2019-2021 | |
| Pfizer INC. | $645.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $407.14 | 2019-2021 | |
| Boston Scientific Corporation | $267.02 | 2019-2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $239.75 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $226.76 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.52 | 2019-2021 | |
| Medtronic Vascular, INC. | $219.71 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $190.69 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $173.82 | 2019-2021 | |
| Intuitive Surgical, INC. | $146.92 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.29 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $95.54 | 2019-2021 | |
| Acutus Medical, INC. | $82.27 | 2020-2021 | |
| Biotronik INC. | $78.00 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $73.08 | 2021 | |
| Cvrx, INC. | $66.89 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $63.05 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $58.03 | 2021 | |
| Amarin Pharma, INC. | $48.64 | 2019-2020 | |
| Abbott Laboratories | $45.25 | 2019-2021 | |
| Nevro Corp. | $32.49 | 2023 | Senza |
| Heartflow, INC. | $29.27 | 2019 | |
| Merck Sharp & Dohme LLC | $27.79 | 2021 | |
| Atricure, INC. | $17.56 | 2019 | |
| Preventice Services, LLC | $15.81 | 2019 | |
| Esperion Therapeutics, INC. | $15.49 | 2020 | |
| Novo Nordisk INC | $14.17 | 2019 | |
| Bardy Diagnostics, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ciccone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.